ALMR — Alamar Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapSucker Stock

Annual balance sheet for Alamar Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2024 December 31st	2025 December 31st
Period Length:	—	—
Source:	PROSPECTUS	PROSPECTUS
Standards:	USG	USG
Status:	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	79.6	30
Net Total Accounts Receivable
Net Total Receivables	7.06	12.8
Total Inventory
Prepaid Expenses
Total Current Assets	107	94.7
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	37.1	38.6
Other Long Term Assets
Total Assets	150	140
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	16.6	23.7
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	47.9	64
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	102	76
Total Liabilities & Shareholders' Equity	150	140
Total Common Shares Outstanding